Consensus statement on the use of clozapine during the COVID-19 pandemic-Reference-Cited by-同舟云学术

Consensus statement on the use of clozapine during the COVID-19 pandemic

Published:2020-05 Issue:3 Volume:45 Page:222-223
ISSN:1180-4882
Container-title:Journal of Psychiatry and Neuroscience
language:en
Short-container-title:jpn

Author:

Siskind Dan,Honer William G.,Clark Scott,Correll Christoph U.,Hasan Alkomiet,Howes Oliver,Kane John M.,Kelly Deanna L.,Laitman Robert,Lee Jimmy,MacCabe James H.,Myles Nick,Nielsen Jimmi,Schulte Peter F.,Taylor David,Verdoux Helene,Wheeler Amanda,Freudenreich Oliver

Publisher

CMA Joule Inc.

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased antipsychotic drug concentration in hospitalized patients with mental disorders following COVID-19 infection: a call for attention;Frontiers in Psychiatry;2024-07-15

2. Evaluating Reduced Blood Monitoring Frequency and the Detection of Hematological Abnormalities in Clozapine-Treated Patients With Schizophrenia: A Chart Review Study From the COVID-19 Pandemic;Schizophrenia Bulletin;2024-07-10

3. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice;European Neuropsychopharmacology;2024-07

4. When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis;CNS Drugs;2024-07-01

5. Change in absolute neutrophil count after COVID-19 infection in patients using clozapine versus other antipsychotics;International Clinical Psychopharmacology;2024-01-22